Clinical significance of Angiopoietin-1 in Behcet's disease patients with vascular involvement

Heart Vessels. 2016 Jun;31(6):918-24. doi: 10.1007/s00380-015-0686-9. Epub 2015 May 12.

Abstract

Behcet's disease (BD) is a chronic multisystem inflammatory disorder of unclear etiology. Vascular inflammation, endothelial dysfunction and angiogenesis may be in part responsible for the pathogenesis of BD. Angiopoietin-1 (Ang-1) is a recent angiogenic mediator. The aim of the present study was to assess Ang-1 in the plasma of BD patients as well as to analyze its association with clinical, and laboratory parameters of the disease. The present study included 47 BD patients and 30 age- and gender-matched healthy controls. Demographic, clinical, disease activity and severity were prospectively assessed. Plasma Ang-1 levels were measured using enzyme-linked immunosorbent assay. The plasma level of Ang-1 in BD patients was significantly lower than healthy controls (p = 0.005). Plasma Ang-1 level in patients with vascular affection was significantly lower than those without vascular affection (p = 0.045). Levels of Ang-1 showed a significant positive correlation with steroid dose. Patients who received cyclophosphamide or steroids showed a significant increase in plasma Ang-1 level. This was further confirmed by the results of the multivariate analysis. There was no significant association between plasma Ang-1 levels and other clinical manifestations or disease activity and severity. Plasma Ang-1 levels were diminished in our BD patients especially in patients with vascular involvement. Larger studies with further investigations of the precise role of Ang-1 in the pathogenesis of BD are needed and might lead to novel therapies for the clinical management of BD.

Keywords: Angiogenesis; Angiopoietin; Behcet’s disease; Vasculitis.

MeSH terms

  • Adult
  • Angiopoietin-1 / blood*
  • Behcet Syndrome / blood*
  • Behcet Syndrome / diagnosis
  • Behcet Syndrome / drug therapy
  • Biomarkers / blood
  • Case-Control Studies
  • Cyclophosphamide / therapeutic use
  • Down-Regulation
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Predictive Value of Tests
  • Prospective Studies
  • Severity of Illness Index
  • Steroids / therapeutic use

Substances

  • ANGPT1 protein, human
  • Angiopoietin-1
  • Biomarkers
  • Immunosuppressive Agents
  • Steroids
  • Cyclophosphamide